TG THERAPEUTICS, INC. (TGTX) Return on equity 2016–2025
TG THERAPEUTICS, INC. (TGTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
69.0%FY2025 · since FY2016: -218.2% → 69.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 69.0% | +58.5 pp |
| FY2024 | 10.5% | +2.6 pp |
| FY2023 | 7.9% | +346.4 pp |
| FY2022 | -338.5% | -191.7 pp |
| FY2021 | -146.8% | -93.0 pp |
| FY2020 | -53.8% | +393.9 pp |
| FY2019 | -447.7% | +274.1 pp |
| FY2018 | -721.8% | -544.9 pp |
| FY2017 | -176.8% | +41.3 pp |
| FY2016 | -218.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice